Viewing Study NCT00450892


Ignite Creation Date: 2025-12-24 @ 3:36 PM
Ignite Modification Date: 2026-01-14 @ 8:38 PM
Study NCT ID: NCT00450892
Status: COMPLETED
Last Update Posted: 2016-07-07
First Post: 2007-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None inflammatory breast cancer View
None stage II breast cancer View
None stage IIIA breast cancer View
None stage IIIB breast cancer View
None stage IIIC breast cancer View